Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Clovis Oncology Inc (CLVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,577,100
  • Shares Outstanding, K 48,180
  • Annual Sales, $ 80 K
  • Annual Income, $ -349,140 K
  • 36-Month Beta 1.73
  • Price/Sales 59,779.02
  • Price/Cash Flow 0.00
  • Price/Book 24.87

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.88 +90.46%
on 05/31/17
96.92 -1.98%
on 06/22/17
+40.02 (+72.79%)
since 05/23/17
3-Month
45.42 +109.16%
on 05/11/17
96.92 -1.98%
on 06/22/17
+26.47 (+38.63%)
since 03/23/17
52-Week
11.57 +721.09%
on 06/27/16
96.92 -1.98%
on 06/22/17
+81.07 (+581.98%)
since 06/23/16

Most Recent Stories

More News
Top-Ranked Health Care ETFs to Buy Now

After many twists and turns, the strong momentum has started to build up in the healthcare space, pushing many stocks and ETFs to multi-year highs.

RYH : 176.32 (+0.11%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
IHF : 149.10 (+0.03%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
Healthcare ETF (IYH) Hits New 52-Week High

This healthcare ETF hit a new 52-week high. Are more gains in store for this ETF?

JNJ : 136.43 (+0.28%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
Top-Ranked Health Care ETFs to Buy Now

After many twists and turns, the strong momentum has started to build up in the healthcare space, pushing many stocks and ETFs to multi-year highs.

RYH : 176.32 (+0.11%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
IHF : 149.10 (+0.03%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
Healthcare ETF (IYH) Hits New 52-Week High

This healthcare ETF hit a new 52-week high. Are more gains in store for this ETF?

JNJ : 136.43 (+0.28%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
Uptrend Call Working As Clovis Oncology Stock Rises 81.3% (CLVS)

SmarTrend identified an Uptrend for Clovis Oncology (NASDAQ:CLVS) on May 18th, 2017 at $52.70. In approximately 1 month, Clovis Oncology has returned 81.33% as of today's recent price of $95.55.

CLVS : 95.00 (-1.84%)
SmarTrend Watching for Potential Pullback in Shares of Clovis Oncology After 1.80% Gain

Clovis Oncology (NASDAQ:CLVS) traded in a range yesterday that spanned from a low of $92.96 to a high of $96.05. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of...

CLVS : 95.00 (-1.84%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.35 (+0.39%)
BBC : 25.10 (+2.45%)
UBIO : 35.35 (+0.51%)
IBB : 320.74 (+0.20%)
BBH : 129.76 (-0.41%)
CLVS : 95.00 (-1.84%)
BIB : 57.19 (+0.30%)
LABU : 71.90 (+4.61%)
XBI : 80.31 (+1.40%)
Clovis Oncology, Inc. (CLVS) Worth a Look: Stock Jumps 6.3%

Clovis Oncology, Inc. (CLVS)) shares rose over 6% on solid volume after the company's announcement regarding the pricing of its shares

CLVS : 95.00 (-1.84%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.35 (+0.39%)
BBC : 25.10 (+2.45%)
UBIO : 35.35 (+0.51%)
IBB : 320.74 (+0.20%)
BBH : 129.76 (-0.41%)
CLVS : 95.00 (-1.84%)
BIB : 57.19 (+0.30%)
LABU : 71.90 (+4.61%)
XBI : 80.31 (+1.40%)
Clovis Oncology Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock

Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that the underwriters of its recently announced public offering of its common stock have exercised in full their option to purchase an...

CLVS : 95.00 (-1.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations....

See More

Support & Resistance

2nd Resistance Point 99.05
1st Resistance Point 97.02
Last Price 95.00
1st Support Level 92.65
2nd Support Level 90.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.